Pinocytosis inhibitory nanoparticles enhance aPD-1 antibody delivery and efficacy while avoiding toxicity in the treatment of solid tumors
{{output}}
While monoclonal antibodies have significantly improved cancer treatment, their accumulation in off-target tissues not only limits efficacy, but also induces toxicity. A major contributor to this problem is the mononuclear phagocyte system (MPS). This collecti... ...
